Eiger BioPharmaceuticals

Eiger BioPharmaceuticals

Biopharmaceutical company developing a diverse portfolio of well-characterized drugs for rare diseases.

HQ location
San Carlos, United States
Launch date
Employees
Market cap
$12.6m
Enterprise value
$8m
Share price
$8.50 EIGR
Recent deals
Authorizing premium user...